Related Experiment Videos
Melioidosis and safety in the clinical laboratory
1Department of Pathology, Townsville General Hospital, Queensland, Australia.
Abstract:
Human infection with Pseudomonas pseudomallei, the causative agent of melioidosis, typically produces subclinical disease and an asymptomatic carrier state; occasionally clinical illness, frequently with a fatal outcome, may occur. Consequently, to help protect staff from laboratory-acquired melioidosis, microbiological and biomedical laboratories must have adequate facilities for safe work procedures and laboratory staff must engage in safe work practices. Recommendations from a melioidosis-endemic, diagnostic laboratory for the prevention of laboratory-acquired infection with this bacterium are essentially Category 3 (Advisory Committee on Dangerous Pathogens), Risk Group 3 (Australian Standards) or Biosafety Level 2 (National Institutes of Health) precautions. These include safeguards for centrifugation, prohibiting the 'sniff' test and the use of a biological safety cabinet for sputum processing, for subculture of stock strains, for preparation of antigen and for research studies but not for routine diagnostic techniques with P. pseudomallei.
Insights
Preventing laboratory-acquired melioidosis requires strict adherence to safety protocols. Implementing Biosafety Level 2 precautions is crucial for protecting laboratory staff from Pseudomonas pseudomallei.
Area of Science:
- Microbiology
- Infectious Diseases
- Occupational Safety
Background:
- Melioidosis, caused by Pseudomonas pseudomallei, often presents asymptomatically but can lead to severe, fatal illness.
- Laboratory-acquired infections pose a significant risk to healthcare and research personnel working with this pathogen.
Purpose of the Study:
- To outline essential safety recommendations for preventing laboratory-acquired melioidosis.
- To detail the necessary precautions for handling Pseudomonas pseudomallei in diagnostic and research settings.
Main Methods:
- Review of safety protocols in a melioidosis-endemic diagnostic laboratory.
- Application of established biosafety guidelines (Category 3, Risk Group 3, Biosafety Level 2).
Main Results:
- Recommended precautions include enhanced centrifugation safety and use of biological safety cabinets.
- Specific procedures like sputum processing, stock strain subculturing, and antigen preparation require stringent containment.
- The 'sniff' test is prohibited due to aerosolization risks.
Conclusions:
- Adherence to Biosafety Level 2 (or equivalent) precautions is vital for safe laboratory work with Pseudomonas pseudomallei.
- Implementing specific safe work practices minimizes the risk of occupational melioidosis.
- Continuous vigilance and proper facility management are key to preventing laboratory-associated infections.